The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.
Open accessAbstract
Autoantibodies in the serum from a patient with connective tissue disease have been used to define a high molecule weight acidic nuclear protein antigen. The antigen tentatively termed Ku, after the first two letters of patient's name, has distinct physicochemical properties and immunological specificities that distinguish it from previously reported antigens. The Ku antigen has an apparent 300,000 mol wt as determined by gel filtration and sucrose density gradient ultracentrifugation techniques. The antigen is destroyed by trypsin, mild heating, and pH variations greater than 10 and less than 5. Treatment with ribonuclease or deoxyribonuclease did not affect the antigenic reactivity. The Ku antigen was demonstrated in the soluble extracts of human, calf, and rabbit, but not of rat tissues. Purified antibody localized the Ku antigen within the nuclei of human liver where a "reticular" pattern of immunofluorescence was seen. Of 330 patients with various connective tissue diseases, 9 had precipitating antibodies to the Ku antigen. Preliminary results of clinical analysis indicated that antibody to the Ku antigen might become a useful marker for a group of patients with clinical characteristics of both polymyositis and scleroderma with a good prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Une micro-méthode de l’immuno-électrophorèse
Scheidegger, J. J. (1955) · International Archives of Allergy and Immunology · doi:10.1159/000228215 · Cited by 3,809
revision of diagnostic criteria for rheumatoid arthritis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-47 · Cited by 2,237
1958 Revision of diagnostic criteria for rheumatoid arthritis
Ropes, M. W., Bennett, G. A., Cobb, S., Jacox, R., & Jessar, R. A. (1959) · Arthritis & Rheumatism · doi:10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9 · Cited by 1,999
DETERMINATION OF NUCLEIC ACIDS IN ANIMAL TISSUES
Ceriotti, G. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70943-5 · Cited by 1,247
IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Koffler, D., Schur, P. H., & Kunkel, H. G. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.4.607 · Cited by 879
Diversity of antinuclear antibodies in progressive systemic sclerosis
Tan, E. M., Rodnan, G. P., Garcia, I., Moroi, Y., Fritzler, M. J., & Peebles, C. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230602 · Cited by 524
Clark, G., Reichlin, M., & Tomasi, T. B. (1969) · The Journal of Immunology · doi:10.4049/jimmunol.102.1.117 · Cited by 502
Measurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus
Pincus, T., Schur, P. H., Rose, J. A., Decker, J. L., & Talal, N. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909252811304 · Cited by 441
Profiles of Antinuclear Antibodies in Systemic Rheumatic Diseases
Notman, D. D., KURATA, N., & TAN, E. M. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-4-464 · Cited by 365
Epidemiology of Systemic Sclerosis (Scleroderma)
MEDSGER, T. A., & MASI, A. T. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-5-714 · Cited by 275
Sharp, G. C., Irvin, W. S., LaRoque, R. L., Velez, C., Daly, V., Kaiser, A. D., & Holman, H. R. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106502 · Cited by 263
The epidemiology of polymyositis
Medsger, T. A., Dawson, W. N., & Masi, A. T. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80006-7 · Cited by 255
Antinuclear antibody with distinct specificity for polymyositis.
Wolfe, J. F., Adelstein, E., & Sharp, G. C. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108616 · Cited by 191
Holman, H. R., & Deicher, H. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103984 · Cited by 147
Akizuki, M., Powers, R., & Holman, H. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108637 · Cited by 123
Self-citationRothfield, N. F., Frangione, B., & Franklin, E. C. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105127 · Cited by 107
Cited by
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Blackford, A. N., & Jackson, S. P. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.015 · Cited by 1,961
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514
The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen
Gottlieb, T. M., & Jackson, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90057-w · Cited by 1,243
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedAutoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine
Tan, E. M. (1982) · Advances in Immunology · doi:10.1016/s0065-2776(08)60836-6 · Cited by 965
Metadata
- Authors
- Mimori, T., Akizuki, M., Yamagata, H., Inada, S., Yoshida, S., & Homma, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1981-09-01
- Volume
- 68
- Issue
- 3
- Pages
- 611-620
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2102687543
- Cited by
- 448
- References
- 17
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.